Shire Strategic Investment Group Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 8
  • Portfolio
  • 1
  • Exits
  • 4

Shire Strategic Investment Group General Information


Shire Strategic Investment Group was Shire's corporate venture fund, tasked with identifying and investing in external innovation that may bring new products to Shire's pipeline and which support Shire's mission to enable people with life-altering conditions to lead better lives. Further to that mission, Shire was focused on delivering novel, cost-effective therapies to patients with symptomatic diseases and significant unmet medical need. Accordingly, the SIG sought to invest across a broad range of therapeutic areas of interest including central nervous system/neuropsychiatry, gastrointestinal, orphan genetic diseases, allergy, and hematology.

Contact Information

Year Founded
Investor Status
Out of Business
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 725 Chesterbrook Boulevard
  • Wayne, PA 19087
  • United States

Shire Strategic Investment Group Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Aptinyx 15-Sep-2015 Seed Round Drug Discovery Generating Revenue/Not Profitable
00000000 000000000 06-May-2013 00000 00000 00.00 Biotechnology Generating Revenue
000000 17-Dec-2012 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3
000000000 15-Oct-2012 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 000000
00000000 000000000 08-Mar-2012 00000 00000 000 Biotechnology Generating Revenue
000000 11-May-2011 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
Prexa Pharmaceuticals 11-May-2011 Early Stage VC 000 Pharmaceuticals Out of Business 00000 00000
Proclara Biosciences 01-Mar-2011 Early Stage VC 000.00 Biotechnology Generating Revenue
To view Shire Strategic Investment Group’s complete investments history, request access »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shire Strategic Investment Group Exits (4)

Company Name Exit Date Exit Type Exit Size
Promedior 13-Feb-2020 Merger/Acquisition 00.000
0000000 21-Jun-2018 000 00000
Naurex 28-Aug-2015 Merger/Acquisition 00.000
Prexa Pharmaceuticals 01-May-2015 Out of Business
To view Shire Strategic Investment Group’s complete exits history, request access »

Shire Strategic Investment Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial